Plaintiffs say Zantac manufacturers have destroyed evidence and intentionally delayed the discovery process for ongoing federal litigation in violation of court orders.…
This week, Sanofi announced intentions to re-launch Zantac under the name Zantac 360, which will use the active ingredient from Pepcid instead of ranitidine, which has been linked to increased cancer risks.…
A Zantac lawsuit filed by a California woman indicates decades of using the now-recalled heartburn drug led to the development of breast cancer.…
A new study links Zantac use, particularly long-term use, with an increased risk of bladder cancer.…
GlaxoSmithKline has sold a plant in India once used to make the recalled heartburn drug Zantac for only a fraction of its initial cost.…
A federal judge has cleared the way for direct filing in Zantac lawsuits through the use of an expedited Short Form Complaint.…
Plaintiffs have filed two amended class action lawsuits in Zantac cancer litigation, seeking for manufacturers to pay for economic losses and medical monitoring for those who took the recalled heartburn drug.…
Two new studies appear to strengthen the science indicating Zantac’s active ingredient, ranitidine, converts to the cancer-causing chemical NDMA duriing digestive processes.…
Plaintiffs involved in 41 federal Zantac lawsuits say their cases were wrongly removed to federal court, and are asking the Zantac MDL judge to remand their cases back to California state courts where they originated.…
Plaintiffs say they plan to show how numerous types of cancer are linked to the side effects of Zantac, which has been recalled due to high levels of the toxic chemical, NDMA.…
